Chapter 4 Basophils. Beyond Effector Cells of Allergic Inflammation

Research output: Contribution to journalArticle

Abstract

Despite being first described in humans nearly 130 years ago, the basophil granulocyte has received little recognition other than being the least common leukocyte circulating in blood. Even after its identity as the source of histamine released by blood cells in response to reaginic IgE, its role in allergic disease has largely been viewed as redundant to that of the tissue mast cell. This line of thought, however, is changing with evidence that has emerged during the last 15 years. Not only have these rare cells been shown to constitute a significant source of cytokines (IL-4 and IL-13) vital to the pathogenesis of allergic disease, but by doing so, may very well modulate T-helper 2-type inflammation at the level of T-cell/dendritic cell interactions. This novel concept combined with the fact that basophils selectively infiltrate allergic lesion sites has sparked greater interest in this once overlooked immune cell, both in adaptive as well as in innate immunity.

Original languageEnglish (US)
Pages (from-to)123-161
Number of pages39
JournalAdvances in Immunology
Volume101
Issue numberC
DOIs
StatePublished - 2009

Fingerprint

Basophils
Inflammation
Interleukin-13
Granulocytes
Innate Immunity
Mast Cells
Cell Communication
Interleukin-4
Dendritic Cells
Immunoglobulin E
Histamine
Blood Cells
Leukocytes
Cytokines
T-Lymphocytes

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Chapter 4 Basophils. Beyond Effector Cells of Allergic Inflammation. / Schroeder, John Thomas.

In: Advances in Immunology, Vol. 101, No. C, 2009, p. 123-161.

Research output: Contribution to journalArticle

@article{1da1298c0f7245d490b3f0f7b6a00d52,
title = "Chapter 4 Basophils. Beyond Effector Cells of Allergic Inflammation",
abstract = "Despite being first described in humans nearly 130 years ago, the basophil granulocyte has received little recognition other than being the least common leukocyte circulating in blood. Even after its identity as the source of histamine released by blood cells in response to reaginic IgE, its role in allergic disease has largely been viewed as redundant to that of the tissue mast cell. This line of thought, however, is changing with evidence that has emerged during the last 15 years. Not only have these rare cells been shown to constitute a significant source of cytokines (IL-4 and IL-13) vital to the pathogenesis of allergic disease, but by doing so, may very well modulate T-helper 2-type inflammation at the level of T-cell/dendritic cell interactions. This novel concept combined with the fact that basophils selectively infiltrate allergic lesion sites has sparked greater interest in this once overlooked immune cell, both in adaptive as well as in innate immunity.",
author = "Schroeder, {John Thomas}",
year = "2009",
doi = "10.1016/S0065-2776(08)01004-3",
language = "English (US)",
volume = "101",
pages = "123--161",
journal = "Advances in Immunology",
issn = "0065-2776",
publisher = "Academic Press Inc.",
number = "C",

}

TY - JOUR

T1 - Chapter 4 Basophils. Beyond Effector Cells of Allergic Inflammation

AU - Schroeder, John Thomas

PY - 2009

Y1 - 2009

N2 - Despite being first described in humans nearly 130 years ago, the basophil granulocyte has received little recognition other than being the least common leukocyte circulating in blood. Even after its identity as the source of histamine released by blood cells in response to reaginic IgE, its role in allergic disease has largely been viewed as redundant to that of the tissue mast cell. This line of thought, however, is changing with evidence that has emerged during the last 15 years. Not only have these rare cells been shown to constitute a significant source of cytokines (IL-4 and IL-13) vital to the pathogenesis of allergic disease, but by doing so, may very well modulate T-helper 2-type inflammation at the level of T-cell/dendritic cell interactions. This novel concept combined with the fact that basophils selectively infiltrate allergic lesion sites has sparked greater interest in this once overlooked immune cell, both in adaptive as well as in innate immunity.

AB - Despite being first described in humans nearly 130 years ago, the basophil granulocyte has received little recognition other than being the least common leukocyte circulating in blood. Even after its identity as the source of histamine released by blood cells in response to reaginic IgE, its role in allergic disease has largely been viewed as redundant to that of the tissue mast cell. This line of thought, however, is changing with evidence that has emerged during the last 15 years. Not only have these rare cells been shown to constitute a significant source of cytokines (IL-4 and IL-13) vital to the pathogenesis of allergic disease, but by doing so, may very well modulate T-helper 2-type inflammation at the level of T-cell/dendritic cell interactions. This novel concept combined with the fact that basophils selectively infiltrate allergic lesion sites has sparked greater interest in this once overlooked immune cell, both in adaptive as well as in innate immunity.

UR - http://www.scopus.com/inward/record.url?scp=60449083521&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60449083521&partnerID=8YFLogxK

U2 - 10.1016/S0065-2776(08)01004-3

DO - 10.1016/S0065-2776(08)01004-3

M3 - Article

C2 - 19231594

AN - SCOPUS:60449083521

VL - 101

SP - 123

EP - 161

JO - Advances in Immunology

JF - Advances in Immunology

SN - 0065-2776

IS - C

ER -